
Sickle Cell Pain: Understanding Its Impact and Personalizing Care
Activity Description
This activity reviews the pathophysiology and clinical presentation of pain in sickle cell disease and applies evidence‑based strategies for acute and chronic pain management. Learners will explore guideline‑supported, patient‑centered approaches and interprofessional care to improve outcomes across care settings.
Target Audience
Learning Objectives
Additional Information
| Attachment | Size |
|---|---|
| 486.54 KB | |
| 281.39 KB |
| Name | Role | Disclosure of Relevant Financial Relationships with Ineligible Company |
|---|---|---|
Marlee M. Grounds, PharmD, BCGP, BCMTMS | Planner | None |
Yoonah P. Kim, PharmD | Planner / Speaker | None |
Kari Muskopf, MSOT, OTR/L | Planner | None |
Mohamed Radhi, MBChB, CPE, FAAP | Planner | None |
Michelle Neumann, RN, BScN, CCM | Planner | None |
JaMilla Thompson, CPhT | Planner | None |
Jason Carr, PharmD, CPh | Independent Reviewer | None |
Disclosures of relevant financial relationships
In accordance with the Accreditation Council for Continuing Medical Education's (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, Centene Institute for Advanced Health Education (Centene Institute) requires all those in control of educational content to disclose their financial relationships with ineligible companies within the prior 24 months. Ineligible companies are defined by the ACCME as companies whose primary business is producing, marketing, selling, re-selling or distributing health care products used by or on patients. Individuals must disclose all financial relationships, regardless of the amount, with ineligible companies and regardless of their view of the relevance of the relationship to the education. Centene Institute ensures that the content is independent of commercial bias.
None of the speakers or planners for this educational event have relevant financial relationship(s) with ineligible companies to disclose, whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Accreditation Statement

Credit Designation Statements

Universal Activity Number UAN JA4008309-0000-26-010-H01-P/T
This program has been pre-approved by The Commission for Case Manager Certification to provide continuing education credit to CCM® board-certified case managers. The course is approved for 0.75 CE contact hour(s). Activity code: I00067584 Approval Number: 260001668 
Available Credit (Listed in Hours)
- 0.75 ACPE Pharmacy
- 0.75 ACPE Technician
- 0.75 AMA PRA Category 1 Credit™
- 0.75 ANCC
- 0.75 Attendance/Participation
- 0.75 CCMC Case Manager
- 0.75 IPCE
Since CE boards may have changes in requirements, it is the responsibility of the attendee to verify with their boards if they accept the CEs being offered
Required Hardware/software
Please ensure you are using the web-browser Chrome and disable any pop-up blocking software.

Facebook
X
LinkedIn
Forward